GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genotech Corp (XKRX:066830) » Definitions » Cash Flow from Others

Genotech (XKRX:066830) Cash Flow from Others : ₩-53 Mil (TTM As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Genotech Cash Flow from Others?

Genotech's cash flow from others for the six months ended in Dec. 2023 was ₩-53 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-53 Mil.


Genotech Cash Flow from Others Historical Data

The historical data trend for Genotech's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genotech Cash Flow from Others Chart

Genotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Others
Get a 7-Day Free Trial Premium Member Only -370.95 8.74 -0.10 -61.90 -53.28

Genotech Semi-Annual Data
Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only -370.95 8.74 -0.10 -61.90 -53.28

Genotech Cash Flow from Others Calculation

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-53 Mil.

Genotech Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Genotech's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Genotech Business Description

Traded in Other Exchanges
N/A
Address
26-69, Gajeongbuk-ro, Yuseong-gu, Daejeon, KOR, 305-343
Genotech Corp is engaged in manufacturing basic pharmaceutical substances and biological agents.

Genotech Headlines

No Headlines